UNVERIFIEDSingle Source
STAT+: What does Akeso’s primo plenary spot say about its survival data?
Stat News|4/30/2026
AB
Adam's Biotech Scorecard
24 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
12
Activity (Last 30 Days)
1
1
1
1
2026-04-022026-04-30
Top Publishers
Stat News12 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway
Stat News|4/16/2026
UNVERIFIEDSingle Source
STAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout
Stat News|3/26/2026
UNVERIFIEDSingle Source
STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: The extremism of the FDA’s Marks and Prasad has come with costs
Stat News|3/5/2026
UNVERIFIEDSingle Source
STAT+: Xenon’s seizure drug study reads out soon. Here’s what to expect
Stat News|2/26/2026
UNVERIFIEDSingle Source
STAT+: What to expect from Gossamer Bio’s late-stage lung disease study
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: The old Vinay Prasad never left. He just changed jobs
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: Nektar Therapeutics is trying to stage a comeback. But a big test awaits
Stat News|2/5/2026